Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors

Journal of Gene Medicine

Volumn 6, Issue 5, 2004, Pages 545-554

  Gruchała, Marcin ^a,c   Bhardwaj, Shalini ^a   Pajusola, Katri ^b   Roy, Himadri ^a   Rissanen, Tuomas T ^a   Kokina, Ilze ^a   Kholová, Ivana ^a   Markkanen, Johanna E ^a   Rutanen, Juha ^a   Heikura, Tommi ^a   Alitalo, Kari ^e   Büeler, Hansruedi ^b   Ylä Herttuala, Seppo ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

AAV; Adenovirus; Artery; Cardiovascular; Gene therapy; Gene transfer; Vector

Indexed keywords

ADENOVIRUS VECTOR; PARVOVIRUS VECTOR; PLACEBO; TIE 1 RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CAROTID ARTERIES; CELL PROLIFERATION; DEPENDOVIRUS; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INFLAMMATION; LEUKOCYTES; MALE; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS (GENETICS); RABBITS; RECEPTOR, TIE-1; TRANSDUCTION, GENETIC; VASCULAR CELL ADHESION MOLECULE-1;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 12344255581     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.535     Document Type: Article

References (21)

1. Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.
2. Nabel EG. Gene therapy for vascular diseases. Atherosclerosis 1995; 118: S51-56.
3. Laitinen M, Pakkanen T, Donetti E, et al. Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum Gene Ther 1997; 8: 1645-1650.
4. Newman KD, Dunn PF, Owens JW, et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955-2965.
5. Schulick AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 1995; 91: 2407-2414.
6. Laitinen M, Makinen K, Manninen H, et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9: 1481-1486.
7. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24-30.
8. Richter M, Iwata A, Nyhuis J, et al. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics 2000; 2: 117-127.
9. Rolling F, Nong Z, Pisvin S, Collen D. Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 1997; 4: 757-761.
10. Nicklin SA, Buening H, Dishart KL, et al. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther 2001; 4: 174-181.
11. Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002; 76: 4580-4590.
12. Puumalainen AM, Vapalahti M, Agrawal RS, et al. β-Galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther 1998; 9: 1769-1774.
13. Grimm D, Kern A, Rittner K, Kleinschmidt JA. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745-2760.
14. Paterna JC, Moccetti T, Mura A, Feldon J, Büeler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther 2000; 7: 1304-1311.
15. Yla-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995; 95: 2692-2698.
16. Hiltunen MO, Turunen MP, Yla-Herttuala S. Gene therapy methods in cardiovascular diseases. Methods Enzymol 2002; 346 311-320.
17. Rome JJ, Shayani V, Flugelman MY, et al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb 1994; 14: 148-161.
18. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
19. Pajusola K, Gruchala M, Joch H, Lüscher TF, Ylä-Herttuala S, Büeler H. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J Virol 2002; 76: 11 530-11 540.
20. Korhonen J, Lahtinen I, Halmekyto M, et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood 1995; 86: 1828-1835.
21. Schwartz SM, Deblois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995; 77: 445-465.